Micro Labs Limited — Levofloxacin Exporter Profile
Indian Pharmaceutical Exporter · #2 for Levofloxacin · $5.0M export value · DGFT Verified
Micro Labs Limited is the #2 Indian exporter of Levofloxacin with $5.0M in export value and 365 verified shipments. Micro Labs Limited holds a 7.0% market share in Levofloxacin exports across 27 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.
Micro Labs Limited — Levofloxacin Export Profile: Buyers & Destinations
Where Does Micro Labs Limited Export Levofloxacin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $1.3M | 80 | 28.6% |
| KENYA | $838.0K | 46 | 17.8% |
| UGANDA | $513.3K | 34 | 10.9% |
| NETHERLANDS | $332.4K | 25 | 7.1% |
| NIGERIA | $295.2K | 17 | 6.3% |
| INDONESIA | $192.7K | 5 | 4.1% |
| MADAGASCAR | $163.1K | 55 | 3.5% |
| VIETNAM, DEMOCRATIC REP. OF | $157.0K | 6 | 3.3% |
| IRAQ | $142.1K | 6 | 3.0% |
| MOZAMBIQUE | $140.9K | 4 | 3.0% |
Micro Labs Limited exports Levofloxacin to 29 countries. The largest destination is FRANCE accounting for 28.6% of Micro Labs Limited's Levofloxacin shipments, followed by KENYA (17.8%) and UGANDA (10.9%). These destinations reflect Micro Labs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Levofloxacin from Micro Labs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| LABOREX UGANDA LIMITED | UGANDA | $1.0M | 60 |
| E.P.DIS | FRANCE | $566.4K | 44 |
| E P DIS | FRANCE | $514.3K | 22 |
| MICRO NOVA PHARMACEUTICALS IND | NIGERIA | $295.2K | 17 |
| E.P.DIS.,., | FRANCE | $252.2K | 12 |
| SEKRETARIAT DITJEN PENCEGAHAN DAN | INDONESIA | $192.7K | 5 |
| AL-KAWKAB SCIENTIFIC BUREAU | JORDAN | $187.7K | 7 |
| DB SCHENKER LOGISTICS NETHERLANDS | NETHERLANDS | $150.9K | 11 |
| CENTRAL DE MEDICAMENTOS Y ARTIGOS | MOZAMBIQUE | $140.9K | 4 |
| M S LABOREX KENYA LIMITED | KENYA | $132.6K | 7 |
Micro Labs Limited supplies Levofloxacin to 60 buyers globally. The largest buyer is LABOREX UGANDA LIMITED (UGANDA), followed by E.P.DIS (FRANCE) and E P DIS (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Levofloxacin Export Value and How Much Does Micro Labs Limited Contribute?
India exported $36.0M worth of Levofloxacin through 6,304 shipments from 699 suppliers to 150 countries, serving 1,543 buyers globally. Micro Labs Limited contributes $5.0M to this total, accounting for 7.0% of India's Levofloxacin exports. Micro Labs Limited ships Levofloxacin to 29 countries through 60 buyers.
What Is the Average Shipment Value for Micro Labs Limited's Levofloxacin Exports?
Micro Labs Limited's average Levofloxacin shipment value is $13.8K per consignment, based on 365 shipments totaling $5.0M. The largest destination is FRANCE (28.6% of Micro Labs Limited's Levofloxacin exports).
How Does Micro Labs Limited Compare to Other Indian Levofloxacin Exporters?
Micro Labs Limited ranks #2 among 699 Indian Levofloxacin exporters with a 7.0% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($9.5M), MICRO LABS LIMITED ($5.0M), SENTISS PHARMA PRIVATE LIMITED ($4.7M). Micro Labs Limited processed 365 shipments to 27 destination countries.
What Levofloxacin Formulations Does Micro Labs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LEVOFLOXACIN DISPERSIBLE TABLETS 100 MG10x10'sx3499=349900 NOS | $129.6K | 3 |
| LEVOBACT 500 ( (Levofloxacin Tablets 500 | $89.8K | 6 |
| LEVOBACT 500 (LEVOFLOXACIN TABLETS 500MGIH) (1X7SX95063) - TAX INVOICE NO: 701208738 DT: 30.04.2024 | $82.0K | 3 |
| LEVOBACT 750 ( (Levofloxacin Tablets 750 | $72.8K | 3 |
| LEVOBACT INFUSION ( (Levofloxacin Infusi | $71.8K | 3 |
| TERLEV INFUSION LEVOFLOXACIN INFUSION 5 | $69.6K | 3 |
| LEVOBACT 750MG ( (Levofloxacin Tablets 750mg IH) ) ( 1X10S ) ( QTY- 7952.000 ) | $67.5K | 2 |
| LEVOFLOXACIN DISPERSIBLE TABLETS 100 mg | $65.5K | 2 |
| LEVOBACT 500 (LEVOFLOXACIN TABLETS 500MGIH) (1X7SX69688) - TAX INVOICE NO: 701208738 DT: 30.04.2024 | $60.1K | 3 |
| LEVOBACT INFUSION ( (Levofloxacin 500mg | $59.0K | 2 |
Micro Labs Limited exports 277 distinct Levofloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LEVOFLOXACIN DISPERSIBLE TABLETS 100 MG10x10'sx3499=349900 N with 3 shipments worth $129.6K.
How Does Micro Labs Limited Compare to Nearest Levofloxacin Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MACLEODS PHARMACEUTICALS LTD | $9.5M | 256 | 34 | $37.2K |
| 2 | MICRO LABS LIMITED ★ | $5.0M | 365 | 27 | $13.8K |
| 3 | SENTISS PHARMA PRIVATE LIMITED | $4.7M | 99 | 5 | $47.6K |
| 6 | KUSUM HEALTHCARE PRIVATE LIMITED | $2.7M | 74 | 7 | $36.3K |
Micro Labs Limited ranks #2 among 699 Indian Levofloxacin exporters. Average shipment value of $13.8K compared to the market average of $51.5K. The closest competitors by value are MACLEODS PHARMACEUTICALS LTD and SENTISS PHARMA PRIVATE LIMITED.
Which Indian Ports Ship Levofloxacin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 670 | 10.6% |
| DELHI AIR CARGO ACC (INDEL4) | 633 | 10.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 620 | 9.8% |
| DELHI AIR | 531 | 8.4% |
| NHAVA SHEVA SEA (INNSA1) | 439 | 7.0% |
| JNPT/ NHAVA SHEVA SEA | 240 | 3.8% |
| JNPT | 186 | 3.0% |
| Bombay Air | 164 | 2.6% |
What Other Antibiotics Products Does Micro Labs Limited Export?
Micro Labs Limited also exports these antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Micro Labs Limited's Levofloxacin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)
Micro Labs Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)
However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.
About Micro Labs Limited
Micro Labs Limited exports 76 products worth $463.6M. Beyond Levofloxacin, top products include Amoxicillin, Potassium, Gabapentin, Losartan, Esomeprazole. View the complete Micro Labs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Levofloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Levofloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 375 individual customs records matching Micro Labs Limited exporting Levofloxacin, covering 277 formulations to 29 countries via 60 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 150+ countries, 1,543+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Levofloxacin Export Data from Micro Labs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Micro Labs Limited's Levofloxacin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Micro Labs Limited
Full Company Profile →
76 products · $463.6M total trade · 21 categories
Levofloxacin Stats
Company Overview
Top Products by Micro Labs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Micro Labs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Levofloxacin. For current shipment-level data, contact TransData Nexus.